Though IL-6 also drives tumor growth and promotes survival of neoplastic cells, these tumor-promoting activities are completely counteracted by the effect of T lymphocyte infiltration into the tumor site with a result of tumor cell killing and tumor regression (81, 83). The gene discussed is IL6; the disease is neoplasm.